Simple Summary The success of HPV as an infectious agent lies not within its ability to
cause disease, but rather in the adeptness of the virus to establish long-term persistent …

Infection with HPV starts with the access of the viral particles to basal cells in the epidermis,
potentially via microtraumas to the skin. The basal cells are able to keep away these …

Purpose: To identify a profile of circulating tumor human papilloma virus (HPV) DNA
(ctHPVDNA) clearance kinetics that is associated with disease control after …

Understanding of oropharyngeal squamous cell carcinoma has significantly progressed
over the last decades, and the concept that this disease can be subdivided into two distinct …

Extrachromosomal DNA (ecDNA) has recently been recognized as a major contributor to
cancer pathogenesis that is identified in most cancer types and is associated with poor …

Persistent infection with certain types of human papillomaviruses (HPVs), termed high risk,
presents a public health burden due to their association with multiple human cancers …

Cellular immunotherapeutics targeting the human papillomavirus (HPV)–16 E6 and E7
proteins have achieved limited success in HPV-positive oropharyngeal cancer (OPC). Here …

The human DNA tumor viruses Epstein–Barr virus (EBV), Kaposi's sarcoma-associated
herpesvirus (KSHV), and human papillomavirus (HPV) share the common property of …

Human papillomavirus (HPV) infection is the cause of the majority of cervical cancers and
head and neck cancers worldwide. Although prophylactic vaccines and cervical cancer …

Every year nearly half a million new cases of cervix cancer are diagnosed worldwide,
making this malignancy the fourth commonest cancer in women. In 2018, more than 270,000 …